http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014274563-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b97cadfe3493436619037687ef7fcb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
| filingDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e16e7bace99ccffa724660abd372217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b6647272edbd0370a93454693103a3 |
| publicationDate | 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2014274563-A1 |
| titleOfInvention | Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy |
| abstract | The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin. |
| priorityDate | 2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.